Kidney Transplant Market- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028
Kidney Transplant |
A kidney transplant is dependent on a variety of conditions
and circumstances, such as renal failure brought on by many causes (kidney
trauma, severe dehydration). It is not a common practise in many nations
because a human can survive for years on just one kidney. Unaffordability is
another factor that prevents people in developing nations from receiving a Kidney Transplant. One of the key
elements influencing the number of kidney transplant procedures is the
availability of a donor.
The global Kidney
Transplant Market is estimated to be valued at US$ 81,037 Mn in 2021 and is
expected to register a CAGR of 3.1% and reach US$ 1,06,179 Mn by 2028.
The most recent epidemic was the coronavirus (COVID-19)
pandemic, which was first identified on December 31, 2019, in Wuhan, China.
Global supply, distribution, and manufacturing of medical goods were all
hampered by the shutdown. Additionally, the number of people visiting hospitals
and clinics has decreased by more than 70% as a result of social isolation
during this pandemic. This has reduced the number of operations, clinical
trials, research and development projects, and other activities, which has hurt
the market's expansion.
Segments covered:
By Type: Living Donor Transplant, Paired
Kidney Transplant, Deceased Donor Transplant
By Age: Children, Adults
By End Users: Hospitals & Clinics, Transplant
Centers
The COVID-19 epidemic has, however, increased the demand for
PPE kits and gloves, which has resulted in a rise in PPE kit production,
supporting the Kidney Transplant
Market growth. When
kidney transplantation rates drop, so do organ procurement rates. The U.K.
recorded a 39% decline in organ referrals in 2020 compared to the previous
year, and France reported a 16% decrease in total deceased organ referrals.
These declines were caused in part by the procurement difficulties transplant
programmes and organisations faced, such as limited testing capacity and
delayed COVID-19 test results, limited operating room availability, and rules
requiring the avoidance of unnecessary clinical activities to protect personnel
and protective equipment.
Major Vendors involved
are Sanofi, Pfizer,
Inc., Novartis AG., B. Braun Melsungen AG, Fresenius Medical Care, Medtronic,
Preservation Solution Inc., TransMedics, Inc., Organ Recovery Systems, and
Transonic Systems Inc.
Comments
Post a Comment